Mitochondria possess their own DNA and transcription and translation machinery for the synthesis of 13 protein subunits for the oxidative phosphorylation system, two rRNAs and 22 tRNAs. In 1988 the first human neurodegenerative diseases associated with mutations in the mitochondrial genome were described. The most recent biochemical and genetic research suggests that mitochondrial disorders are best categorized as: (i) primary mutations of the mitochondrial DNA, either sporadic or maternally inherited; (ii) nuclear mutations that result in alterations in mitochondrial DNA or intergenomic signalling defects; or (iii) Mendelian defects that affect the respiratory chain in the absence of mitochondrial DNA mutations. There is still little information about the pathophysiology of these different disorders. In order to obtain some insight into the cellular mechanisms of neurodegeneration, we examined cultured fibroblasts from patients with the MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes) syndrome, which is most frequently caused by a mutation in the mitochondrial tRNA for leucine. We found that their basal level of ionized calcium was elevated and that they could not normally sequester calcium influxes induced by depolarization. In addition, they were unable to maintain normal mitochondrial membrane potentials, as determined using a voltage-sensitive fluorescent indicator. Despite these physiological perturbations, the MELAS fibroblasts had normal concentrations of ATP. If neurons in MELAS patients have similar physiologi-
at position 3243 in the leucine tRNA responsible for assembling proteins within the mitochondria. Less commonly seen is a T→C substitution at position 3271 in the same tRNA codon. The MELAS syndrome is frequently characterized by maternal inheritance, with affected mothers sometimes less severely involved than offspring. The mutation can be present in different proportions in different body tissues (heteroplasmy), with the level of the mutation in muscle correlating better with disease severity than the level in white blood cells [8] . Onset of this syndrome is typically in childhood, although adult-onset cases have been reported [9] .
MERRF (myoclonus epilepsy with RRFs) is another maternally inherited, childhood-onset, mitochondrial cytopathy associated with point mutations in a mitochondrial tRNA; in this case at positions 8344 or 8356 in tRNA lys . The clinical phenotype of this disease includes progressive myoclonus, generalized seizures, dementia and deafness. Point mutations at position 8993 (either T→G or T→C ) in the ATPase subunit 6 gene produce the NARP (neurogenic weakness, ataxia and retinitis pigmentosa) syndrome. This illness is maternally inherited, but lacks RRF, since mitochondrial protein synthesis is not disrupted. When the level of mtDNA with these mutations exceeds 95%, patients actually demonstrate the Leigh's syndrome phenotype: psychomotor retardation, opthalmoplegia, movement disorders, dysphagia, respiratory irregularity and vomiting.
Bilateral visual loss, usually with second or third-decade onset, can be produced by maternally transmitted mtDNA mutations affecting several of the respiratory chain subunits and is called Leber hereditary optic neuropathy (LHON). Most of the identified mtDNA mutations in this syndrome affect complex I (subunits 1, 4 or 6). This illness shows a strong male preponderance, possibly explained by an X-linked nuclear gene [10] . Whereas the most prominent target in LHON is the visual system, there are patients with this syndrome who develop other neurological signs and symptoms, including dystonia, hyper-reflexia and neuropathy.
There are two types of intergenomic defect identified to date. Multiple familial mtDNA deletions can occur as either autosomal-dominant or -recessive diseases [11] [12] [13] . The former appears in the third decade with ophthalmoplegia, weakness and exercise intolerance. Patients have lactic acidosis and RRF and mitochondria have multiple deletions. In some undetermined way a nuclear mutation alters mtDNA division or error correction [14] . The autosomal-recessive form of this disease has a childhood onset and is much more severe, with a cardiomyopathy. The second type of intergenomic defect is mtDNA depletion. There are three different childhood-onset syndromes: fatal congenital myopathy, late infantile myopathy and infantile hepatopathy. In all three syndromes there is an enormous decrease in mtDNA, probably secondarily to an autosomal-recessive defect in a gene governing mtDNA replication.
A large number of nuclear genetic illnesses, recently reviewed by DeVivo, affect oxidative phosphorylation or the respiratory chain, without directly influencing the mitochondrial genome [3] . Functional deficiencies of complexes I, II, III, IV and V have all been identified, although the specific nuclear mutations have not been isolated. The most recognizable phenotype is Leigh's syndrome, an early-onset encephalomyopathy associated with developmental delay, ophthalmoplegia, movement disorders, hypo-or hyperventilation and sometimes seizures. Most cases of Leigh's syndrome are caused by deficiency of cytochrome oxidase activity and inherited as an autosomal-recessive trait. However, it can also be associated with deficiencies in pyruvate dehydrogenase activity. Pyruvate dehydrogenase is itself a complicated enzyme, with subunits coded for on chromosomes 3 and 7 and the X chromosome, explaining the observation of both autosomal-recessive and X-linked inheritance in Leigh's syndrome. As mentioned above, there is also a maternally inherited form of Leigh's syndrome associated with high levels of mtDNA mutated at the 8933 position.
Cellular pathophysiology of the MELAS syndrome
Despite the large amount of information about the molecular biology and genetics of the mtDNA mutations, there is still little information about the cellular pathophysiology of the systemic and neurological deficits associated with these diseases. Impaired ATP production was an obvious candidate for the cellular dysfunction in these syndromes, but we sought to determine a more specific link between neurological and muscular damage and mitochondrial defects. Specifically, we evaluated whether an inability to buffer rises in ionized intracellular calcium (Ca i 2ϩ ) might, in part, underlie increased sensitivity to physiological stresses, since there is compelling evidence linking elevated Ca i 2ϩ to toxic cell damage and mitochondria are known to buffer Ca i 2ϩ [15, 16] . Our original experimental results have already been published [17] .
We examined Ca i 2ϩ and mitochondrial energy state in cultured fibroblasts obtained from control patients and patients with MELAS and KSS syndromes (see Table 1 ; [17] ). We anticipated that any disturbed cellular physiology would be reflected in MELAS fibroblasts, which were selected to contain high levels of the mutation [18] . We would have preferred to examine muscle or neurons, but that was unrealistic. We studied 2-4 sister dishes per passage and analysed a minimum of 2 passages per patient. Passage number for most cultures ranged between 1 and 13 (except for C10 and M5, which were previously cultured in other laboratories). The control cultures (C1-C14 in Table 1 ) lacked clinical or biochemical evidence of mitochondrial defects. Analysis of fibroblast cultures in the MELAS group identified single point mutations at nt 3243 (patients M1-M3 in Table 1 ), nt 3271 (patient M4) and nt 8344 (patient M5; this patient presented clinically with MELAS but, subsequent to our analysis, was found to express the point mutation typical of MERRF syndrome, see [4] ). The percentages of mutant mtDNA in these fibroblasts were: M1 ϭ 71%; M2, not tested in fibroblasts, 64% in muscle; M3 ϭ 46%; M4ϭ67%; and M5 ϭ 61% [18] . Southern-blot analysis of fibroblasts in the KSS group identified no mtDNA deletion in patients K1 and K3, 18% and 12% deletion in patients K2 and K4, respectively (the K2 deletion was 5 kb, position was not determined; K4 deletion size and position were not determined) [19] .
The low levels of mutated mtDNA in the KSS group were expected in fibroblasts; levels would have been much higher in muscle.
We loaded the cultured fibroblasts with the calcium-sensitive, fluorescent dye fura-2 acetoxymethyl ester and used standard quantitative fluorescenceimaging techniques to measure levels of Ca i 2ϩ in individual fibroblasts. The dye's fluorescence changes upon binding calcium have been well characterized and allow determination of Ca i 2ϩ after suitable calibration of the imaging system [20] . The baseline calcium value (Table 1) for a given patient consisted of Figure 1 ). Ca i 2ϩ levels in our control patients were nearly identical to values from human fibroblasts found by other laboratories [21]. An additional control for baseline Ca i 2ϩ was provided by fibroblasts obtained from patients with KSS, which express very little or no mtDNA deletions in vitro and have baseline Ca i 2ϩ levels not significantly different from controls (Table 1 and Figure 1A ). We were also concerned that there might be age-or sex-related differences among cultures, but regression analysis of all patients for whom age and sex at time of biopsy were known showed no correlation between age or sex and baseline Ca i 2ϩ measurements (P ϭ
We also measured Ca i 2ϩ after depolarization with 60 mM potassium, which activates voltage-sensitive calcium channels, and found that the Ca i 2ϩ response also differed between fibroblasts from control and MELAS patients. When switched to extracellular solution containing 60 mM potassium, Ca i 2ϩ in control cells increased transiently and then returned to baseline within 3-5 min even in the continued presence of elevated potassium ( Figure 1B) . In cells from the MELAS patients, exposure to high potassium caused sustained (у20 min) elevations in Ca i 2ϩ levels that were significantly above baseline (Figure 1 ). Of the 520 MELAS fibroblasts, 82 maintained their Ca i 2ϩ at greater than 2 standard deviations above baseline after a 20 min exposure to elevated potassium, compared with 0 of the 584 control fibroblasts (P Ͻ0.001 by ⌾ 2 test). Prolonged exposure (24 h) to elevated potassium did not result in cell death in either control or MELAS fibroblasts, as assessed by Trypan Blue exclusion. In addition, control fibroblasts treated with 1 mM 3-NPA exhibited abnormal calcium responses to 60 mM potassium depolarization very similar to that observed in MELAS fibroblasts, in that Ca i 2ϩ remained signficantly elevated above baseline for extended periods of time.
One possible explanation for the pathological Ca i 2ϩ levels in the MELAS fibroblasts was that low ATP levels might interfere with Ca i 2ϩ extrusion and sequestration. In order to test this possibility, we assayed ATP levels in both control and MELAS fibroblast cultures to determine whether mitochondrial impairment decreased ATP concentrations [22] . ATP levels in controls were 136 Ϯ 56 mol of ATP per g of total protein (n ϭ 6) compared with 152 Ϯ 46 in MELAS cultures (n ϭ 3; P Ͼ0.6). These values are similar to ATP levels reported by several other investigators for cultured human fibroblasts [23, 24] . This indicates that MELAS fibroblasts grown under our culture conditions produce normal levels of ATP glycolytically or that the fraction of wild-type mtDNA present in MELAS fibroblasts allows sufficient mitochondrial ATP production. In either case, a global ATP deficiency cannot explain the elevation in MELAS fibroblasts.
Another possible mechanism to explain the Ca i 2ϩ differences between control and MELAS fibroblasts would be differing resting plasma-membrane potentials, which may in turn affect calcium influx through voltage-sensitive calcium channels. Using direct intracellular recording, the resting potential of S.M. Rothman Figure 2 Mitochondrial polarization determined by quantitative confocal microscopy. (A) Imaging mitochondria in fibroblasts from control and MELAS patients with the ratiometric dye JC-1. Representative age-and sexmatched control (top panels) and MELAS (bottom panels) fibroblasts are shown. Left (a1, b1), the potential-sensitive 590 nm emission; centre (a2, b2), the 527 nm emission, which is similar in both cells and reveals all mitochondria; right (a3, b3), the 590/527 ratio image. A binary mask of the 527 nm image was applied to the ratio to eliminate all non-mitochondrial features. Scale bar, 10 m. (B) Analysis of mitochondrial membrane potential in MELAS and control fibroblasts stained with JC-1. Histogram of the entire data set (Ͼ5 000000 pixels) is skewed towards a lower ratio for the MELAS mitochondria. Pixel data from control and MELAS ratio images were separated into bins of 0.25 ratio units. The final bin holds pixels with a ratio у5. The cumulative total is plotted above each set of bins for both data sets. When an arbitrary ratio value of 1 is used to distinguish quiescent (Ͻ1) and energized (у1) mitochondria, over 89% of MELAS mitochondria, as a population, are quiescent, compared with 78% of ☞ control fibroblasts was Ϫ49.2 Ϯ 4.8 mV (n ϭ 23 cells), compared with Ϫ48.1 Ϯ 3.8 mV (n ϭ 19) for the MELAS fibroblasts. The difference in values between the two populations of cells was insignificant (P Ͼ0.4). This finding also makes it unlikely that voltage-sensitive calcium channels, and therefore calcium entry, is different between control and MELAS cells at rest. In addition, the magnitude of calcium elevation following depolarization (i.e. net calcium increase), as measured by fura-2, was similar in both control and MELAS cells (Figure 1B) , even though the resting calcium levels in MELAS fibroblasts are significantly elevated above the control baseline. This suggests that calcium influx through voltage-sensitive calcium channels is not significantly different in control and MELAS fibroblasts.
We then determined whether the MELAS mutation leads to reduced mitochondrial membrane potential. Normally, the electron-transport chain maintains a steep potential gradient, ranging between Ϫ150 and Ϫ180 mV, across the inner mitochondrial membrane. We reasoned that an abnormally low gradient could diminish Ca i 2ϩ uptake through the mitochondrial calcium uniport and impair Ca i 2ϩ sequestration by MELAS mitochondria. Therefore, we assessed the membrane potential of individual mitochondria in intact fibroblasts using confocal microscopy. This technique avoids the confounding effects that arise in disrupted cell preparations necessary in standard biochemical assays. We employed the dual-emission dye 5,5Ј,6,6Ј-tetrachloro-1,1Ј, 3,3Ј-tetraethylbenzimidazolocarbocyanine (JC-1), recently introduced by Reers and colleagues [25, 26] . JC-1 selectively labels mitochondria and reports mitochondrial membrane potential as a function of 'dye-aggregation state'. JC-1 is maximally excited at 490 nm and has emission maxima at 527 and 590 nm. The fluorescence intensity of the 527 nm emission is insensitive to changes in mitochondrial potential, whereas the 590 nm emission linearly increases as a function of mitochondrial potential, due to micellar dye aggregation (Figure 2A) . We have developed a semi-quantitative measurement of mitochondrial membrane potential in situ, using the intensity ratio of the 590/527 emissions ( Figure 2A) .
As expected, preliminary experiments established that mitochondrial uncouplers reduced the 590/527 JC-1 ratio in control fibroblasts. The electrontransport-chain inhibitors rotenone (1 M) and antimycin (1 M) both decreased ratio values over 25-55 min. Also as expected, when the mitochondrial membrane potential was abolished with the protonophore FCCP (1 M), JC-1 quickly redistributed to the cytosolic compartment.
Using the ratio-imaging technique, we compared mitochondria in control and MELAS fibroblasts. Our method of analysis was influenced by our own Figure 2 (contd.) control mitochondria (see dotted lines). Inset, an alternative method of analysis uses the same data set, but segregrates the data by individual patient instead of pooling all pixels (see Table 1 ). When the two groups are compared in this way, the percentage of energized mitochondria (ratio у1) is still twice as high in the control group (**, P ϭ 0.002 by Mann-Whitney U test; bars represent means Ϯ S.E.M. and others' observations that the 590 nm emission from JC-1-loaded fibroblasts is not uniform [26] . There are regions of mitochondria with intense 590 nm fluorescence (J-aggregates or 'hot spots') that represent a fraction of the total mitochondrial area. Computing an average 590/527 ratio over the entire mitochondrial area would, therefore, provide a misleading indication of mitochondrial membrane polarization. Instead, we designed a relative measurement of polarized mitochondrial membrane potential using JC-1 ratio imaging of randomly chosen fields of control and MELAS fibroblasts. We first examined the total distribution of 590/527 ratio values in both control and MELAS data sets (Ͼ5000 000 pixels). The cumulative histogram is clearly skewed towards the higher ratios in the control fibroblasts ( Figure 2B ). As a second method of analysis, we determined the fraction of mitochondrial pixels per cell using an arbitrarily defined ratio value of у1 for each patient and then averaged the data by patient (Table 1 and Figure 2B , inset). Initially, this arbitrary ratio value of 1 was used to provide a measure of mitochondrial regions with J-aggregate formation (which is the numerator of the 590/527 ratio) and thus is indicative of the most highly 'energized' regions of mitochondrial membrane potential. We found that approximately 20% of the mitochondrial area of control fibroblasts was 'energized', as defined in this way, while less than 10% of the area of MELAS mitochondria was similarly energized. We recognize that the initial definition of ratio values у1 is an arbitrary division of 'quiescent' and 'energized' mitochondrial membrane potential. However, when the final histogram distribution was subsequently obtained, we found that for every ratio value у0.5 in the histogram, the representation of control mitochondria exceeds that of MELAS mitochondria ( Figure 2B ).
Qualitative examination of the JC-1 images is consistent with these observations. There are many hot spots of intense 590 nm fluorescence in mitochondria from control fibroblasts that are nearly absent from MELAS cells (Figure 2A, a1 and b1 ). Regression analysis of control patients listed in Table 1 showed no correlation between mitochondrial membrane potential, as measured by this method, and patient age or sex in the control group (P ϭ 0.24 and 0.40 for age and sex, respectively; t-test for variances).
Our results indicate that fibroblasts cultured from patients with MELAS syndrome have sustained abnormalities of calcium homoeostasis and mitochondrial membrane potential. Whereas the experimental manipulations employed in this study to increase cytosolic calcium were not toxic to either control or MELAS fibroblasts, we postulate that even modest Ca i 2ϩ elevation, persisting over months or years, could lead to cell injury or death. The cells most vulnerable to calcium-dependent injury would be those that are electrically active, neurons and muscle cells which experience large calcium influxes during synaptically mediated depolarizations. These are the cells most often affected in MELAS patients [3, 4, 18, 19] . Additionally, mitochondrial compromise may sensitize vulnerable cells to other insults, such as glutamate-induced neurotoxicity. This may account for the neuroprotective effects of glutamate antagonists in some animal models in which mitochondrial toxins produce selective striatal injury [27, 28] .
There are other interesting aspects to this work as well. There was some variability in baseline values and in Ca i 2ϩ responses to depolarization. The sustained Ca i 2ϩ rises were not seen uniformly in all cells from cultures with mitochondrial defects, presumably because of the heterogeneity of wild-type and mutant mtDNA in these cells [4] . This may reflect the fact that mitochondrial mutations are cytoplasmically inherited during cell division. All cells and tissues may not inherit the same proportion of mutant and wild-type mitochondria, so both types of mitochondria may co-exist within individual cells. There is a threshold for the percentage of mutant DNA, possibly exceeding 90%, required for the development of clinical symptoms in the mitochondrial encephalomyopathies [29] . The observed Ca i 2ϩ variations may be the cellular concomitant of this threshold effect.
We have confirmed the original observation by Smiley and colleagues that JC-1 reveals heterogeneities in mitochondrial membrane potential in a variety of cell types [26] . Our results are also completely consistent with a recent description of diminished mitochondrial membrane potential in MELAS and MERRF fibroblasts using the methyltriphenyl-phosphonium bromide method [30] . The decreased electrochemical gradient for Ca i 2ϩ across the mitochondrial membrane may result in diminished calcium buffering by the mitochondria in these cells. There is already experimental verification that mitochondria contribute to cytosolic calcium homoeostasis in many cell types [31, 32] .
Our observations do not show precisely how the primary genetic defect in MELAS translates into abnormal mitochondrial polarization. A reasonable hypothesis is that the mutated leucine tRNA results in functionally defective mitochondria that are unable to sustain normal mitochondrial membrane resting potential. In any case, these results provide the first clear documentation of an abnormality of Ca i 2ϩ homoeostasis in a human encephalomyopathy and may have relevance to the 'impaired energy' hypothesis in human neurodegenerative diseases [27, 28] .
